Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma Limited has filed its financial results with the NSE for the quarter and half-year ended September 30, 2025. This is a standard regulatory filing notification confirming that the company's Q2 FY2026 results have been submitted to the exchange. The actual detailed numbers (revenue, profit, margins) would be available in the accompanying results document, which is not included in this headline notice. Retail investors should review the full results PDF for segment-wise performance and management commentary.
Neutral short-term — this is a routine compliance filing rather than a material event. The actual stock reaction will depend on the numbers in the detailed results document (revenue growth, margins, profit) which are yet to be analysed.